Negative Breast Cancer Market Insight, Epidemiology and Market Forecast - 2035" report delivers comprehensive insights into triple-negative breast cancer, i ...

Triple-negative breast cancer (TNBC), a subgroup that lacks expression ... genes Breast cancers occurring in patients with germline BRCA1 mutations are often triple negative and basal like ...

Gilead Sciences has cemented the role of its TROP2 drug Trodelvy in triple-negative breast cancer (TNBC) with a win in a phase 3 combination trial with MSD's PD-1 inhibitor Keytruda. ASCENT-04 ...

Surgery may not be the best next course of treatment for patients with early-stage breast cancer who had a complete response to neoadjuvant (pre-surgical) chemotherapy and standard radiation treatment ...

Tumor-negative breast cancers misclassified as ... Adjuvant trastuzumab has significantly improved the prognosis of breast cancer patients both in terms of disease-free survival and overall ...

BriaCell confirms complete resolution of lung metastasis at 4 months in Phase 1/2a trial using Bria-OTS immunotherapy in advanced breast cancer.

Before I knew and the doctors knew." Doctors diagnosed Bortner with stage 2B triple-negative invasive ductal carcinoma, a type of breast cancer that has fewer treatment options than other types of ...

Gilead Sciences has cemented the role of its TROP2 drug Trodelvy in triple-negative breast cancer with a study win in combination with MSD's Keytruda. The importance of biosimilars only continues ...

Immunotherapy is a type of biologic therapy that helps your immune system recognize and attack cancer cells. It’s only used for triple-negative breast cancer, an aggressive and less common form ...

BRCA1/2 tPV Status Insights A significant aspect of the ... specifically comparing nab-paclitaxel combined with carboplatin versus gemcitabine, in early-stage triple-negative breast cancer (TNBC) ...